213 related articles for article (PubMed ID: 17099224)
1. Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS.
Sun Y; Ding L; Zhang H; Han J; Yang X; Yan J; Zhu Y; Li J; Song H; Ye Q
Nucleic Acids Res; 2006; 34(21):6314-26. PubMed ID: 17099224
[TBL] [Abstract][Full Text] [Related]
2. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
Altomare D; Velidandla R; Pirisi L; Creek KE
BMC Cancer; 2013 Sep; 13():424. PubMed ID: 24047375
[TBL] [Abstract][Full Text] [Related]
3. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
4. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of Smad-responsive motifs identifies multiple regulatory inputs for TGF-β transcriptional activation.
Itoh Y; Koinuma D; Omata C; Ogami T; Motizuki M; Yaguchi SI; Itoh T; Miyake K; Tsutsumi S; Aburatani H; Saitoh M; Miyazono K; Miyazawa K
J Biol Chem; 2019 Oct; 294(42):15466-15479. PubMed ID: 31481467
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
7. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
Qureshi HY; Ricci G; Zafarullah M
Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
11. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Smad-mediated gene transcription by RGS3.
Yau DM; Sethakorn N; Taurin S; Kregel S; Sandbo N; Camoretti-Mercado B; Sperling AI; Dulin NO
Mol Pharmacol; 2008 May; 73(5):1356-61. PubMed ID: 18287247
[TBL] [Abstract][Full Text] [Related]
13. Functions of Smad Transcription Factors in TGF-β1-Induced Selectin Ligand Expression on Murine CD4 Th Cells.
Ebel ME; Kansas GS
J Immunol; 2016 Oct; 197(7):2627-34. PubMed ID: 27543612
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
15. Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit.
Chen F; Ogawa K; Liu X; Stringfield TM; Chen Y
Biochem J; 2002 Jun; 364(Pt 2):571-7. PubMed ID: 12023901
[TBL] [Abstract][Full Text] [Related]
16. Activin A induces neuronal differentiation and survival via ALK4 in a SMAD-independent manner in a subpopulation of human neuroblastomas.
Suzuki K; Kobayashi T; Funatsu O; Morita A; Ikekita M
Biochem Biophys Res Commun; 2010 Apr; 394(3):639-45. PubMed ID: 20226172
[TBL] [Abstract][Full Text] [Related]
17. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
He WX; Niu ZY; Zhao SL; Smith AJ
Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
19. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.
Poncelet AC; Schnaper HW; Tan R; Liu Y; Runyan CE
J Biol Chem; 2007 May; 282(21):15534-40. PubMed ID: 17400544
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1-Smad signaling pathways are not required for epidermal LC homeostasis.
Li G; Gao XH; Mi QS
Oncotarget; 2016 Mar; 7(13):15290-1. PubMed ID: 27003361
[No Abstract] [Full Text] [Related]
[Next] [New Search]